GlassScriptPhysician profile
Thomas Schwartzer
NPI 1649297110
$3,562.17
in general payments reported to CMS, 2019-2025
43 companies · $615 in 2025
The $615 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $202 · 2021: $344 · 2022: $284 · 2023: $746 · 2024: $601 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,962.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $545.58 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $321.57 | 2021-2025 | Ubrelvy, Vraylar |
| Glaxosmithkline, LLC. | $264.97 | 2019-2025 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $252.85 | 2019-2024 | Breztri |
| Lilly USA, LLC | $179.71 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Amgen INC. | $160.28 | 2022-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $153.48 | 2019-2025 | |
| Abbott Laboratories | $152.07 | 2021-2024 | Freestyle Libre 3 |
| Exact Sciences Corporation | $144.95 | 2023-2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $110.85 | 2019-2023 | Injectafer |
| Mannkind Corporation | $103.71 | 2019-2024 | |
| Eisai INC. | $91.71 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.63 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $86.35 | 2019-2025 | Capvaxive |
| Sanofi Pasteur INC. | $75.43 | 2019-2025 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Schwartzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.